Amundi’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$874K Buy
30,952
+3,312
+12% +$88.5K ﹤0.01% 1330
2025
Q4
$767K Sell
27,640
-13,877
-33% -$334K ﹤0.01% 1332
2025
Q3
$965K Buy
41,517
+14,100
+51% +$313K ﹤0.01% 1164
2025
Q2
$489K Buy
27,417
+27,416
+2,741,600% +$442K ﹤0.01% 1382
2025
Q1
$15 Sell
1
-142
-99% -$2.4K ﹤0.01% 2188
2024
Q4
$2.65K Buy
143
+59
+70% +$1.22K ﹤0.01% 1973
2024
Q3
$1.5K Buy
+84
New +$1.53K ﹤0.01% 1957

Other funds holding PHVS

Amundi's PHVS Position: Q1 2026 in Review

Amundi increased its Pharvaris (PHVS) stake by 12% in Q1 2026, buying an estimated $88.5K and bringing the position to 30,952 shares worth $874K. The position accounts for ﹤0.01% of the portfolio, ranked #1330.

Amundi first reported a position in PHVS in Q3 2024 and has held it in 7 quarters since. The position peaked at $965K in Q3 2025. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

  • Amundi held 30,952 shares of Pharvaris worth $874K as of Q1 2026.
  • Amundi bought 3,312 Pharvaris shares in Q1 2026, an estimated $88.5K.
  • Pharvaris made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1330 holding.
  • Amundi first reported a position in Pharvaris in Q3 2024 and has held it in 7 quarters since.
  • Amundi's Pharvaris position peaked at $965K in Q3 2025.
  • 110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.